Sri Krishna Pharmaceuticals Limited

Produces bulk drugs and DC granules, with five manufacturing units in Hyderabad and Solapur.

1974 | Hyderabad, Telangana (India) | Active
Last Updated:

Sri Krishna Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 11.92 Cr
  • Company Age 50 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 287.16 Cr
  • Satisfied Charges ₹ 184.84 Cr
  • Revenue Growth -3.35%
  • Profit Growth -52.42%
  • Ebitda -34.08%
  • Net Worth 1.61%
  • Total Assets 2.41%

About Sri Krishna Pharmaceuticals

Sri Krishna Pharmaceuticals Limited (SKPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 September 1974 and has a history of 50 years and six months. Its registered office is in Hyderabad, Telangana, India.

The Corporate was formerly known as Sri Krishna Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 11.92 Cr.

The company currently has active open charges totaling ₹287.16 Cr. The company has closed loans amounting to ₹184.84 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Sri Krishna Pharmaceuticals Limited India are Nikhil Pandey as Cfo, Kalluru Manaswini as Company Secretary, and Kalluru Manaswini as Company Secretary. Venkatakrishna Vempalli, Muri Madhusudhan, Pranesh Mathur, and Three other members serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230TG1974PLC001790

  • Company No.

    001790

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    26 Sep 1974

  • Date of AGM

    31 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Sri Krishna Pharmaceuticals Limited offer?

Sri Krishna Pharmaceuticals Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Crocin Advance Tablet, Crocin Tablets.

Who are the key members and board of directors at Sri Krishna Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Venkatakrishna Vempalli Country flag representing In Managing Director15-Oct-1997Current
Nikhil Pandey Country flag representing In CFO14-Oct-2024Current
Kalluru Manaswini Country flag representing In Company Secretary26-Dec-2023Current

Board Members (5)

NameDesignationAppointment DateStatus
Pranesh Mathur Country flag representing In Whole-Time Director 17-Feb-2014Current
Muri Madhusudhan Country flag representing In Additional Director 24-Sep-2024Current
Sunitha Reddivari Country flag representing In Director 01-Feb-2023Current
Venkata Vempalle Country flag representing In Whole-Time Director 26-Sep-1974Current
Venkateswar Sarvepalli Country flag representing In Director 31-Oct-2014Current

Financial Performance of Sri Krishna Pharmaceuticals.

Sri Krishna Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.35% decrease. The company also saw a substantial fall in profitability, with a 52.42% decrease in profit. The company's net worth moved up by a moderate rise of 1.61%.

Sri Krishna Pharmaceuticals revenue growth over time
Sri Krishna Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-3.35%
Revenue from Operations
-3.15%
Total Assets
2.41%
Profit or Loss
-52.42%
Net Worth
1.61%
EBITDA
-34.08%

What is the Ownership and Shareholding Structure of Sri Krishna Pharmaceuticals?

In 2023, Sri Krishna Pharmaceuticals had a promoter holding of 89.09% and a public holding of 10.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹287.16 Cr

Satisfied Charges

₹184.84 Cr

Charges Breakdown by Lending Institutions

  • Others : 157.00 Cr
  • Axis Bank Limited : 85.16 Cr
  • Citi Bank N.A. : 45.00 Cr

Latest Charge Details

DateLenderAmountStatus
28 Mar 2024Others₹30.00 CrOpen
26 Apr 2021Citi Bank N.A.₹9.00 CrOpen
30 Mar 2021Others₹10.00 CrOpen
07 Jan 2021Others₹77.00 CrOpen
22 Oct 2018Others₹40.00 CrOpen

How Many Employees Work at Sri Krishna Pharmaceuticals?

Sri Krishna Pharmaceuticals has a workforce of 1459 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Sri Krishna Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Krishna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Krishna Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sri Krishna Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Nikhil Bihari Pandey was appointed as a Cfo was appointed as a Cfo on 14 Oct 2024 & has been associated with this company since 5 months 13 days .

  • Director Appointment

    Muri Reddy Madhusudhan was appointed as a Additional Director was appointed as a Additional Director on 24 Sep 2024 & has been associated with this company since 6 months 3 days .

  • Annual General Meeting

    Sri Krishna Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2024 as per latest MCA records.

  • Balance Sheet

    Sri Krishna Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Charges

    A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100904872 was registered on 28 Mar 2024.

  • Director Appointment

    Kalluru Manaswini was appointed as a Company Secretary was appointed as a Company Secretary on 26 Dec 2023 & has been associated with this company since 1 year 3 months .

Frequently asked questions

  • What is the Incorporation or founding date of Sri Krishna Pharmaceuticals Limited?

    Sri Krishna Pharmaceuticals Limited was incorporated on 26 Sep 1974.

  • What is authorized share capital and paid-up capital of Sri Krishna Pharmaceuticals Limited?

    The authorized share capital of Sri Krishna Pharmaceuticals Limited is ₹ 15.00 Cr and paid-up capital is ₹ 11.92 Cr.

  • Who are the current board members & directors of Sri Krishna Pharmaceuticals Limited?

    Currently 9 directors are associated with Sri Krishna Pharmaceuticals Limited.

    • Venkatakrishna Reddy Vempalli
    • Muri Reddy Madhusudhan
    • Pranesh Raj Mathur
    • Nikhil Bihari Pandey
    • Kalluru Manaswini
    • Sunitha Reddy Reddivari
    • Venkata Subba Reddy Vempalle
    • Venkateswar Rao Sarvepalli
    • Kalluru Manaswini

  • What is the registered address of Sri Krishna Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sri Krishna Pharmaceuticals Limited is C-4 Industrial Area, Uppal Hyderabad India, Telangana, 500039.

  • What is the corporate identification number (CIN) and company number of Sri Krishna Pharmaceuticals Limited?

    The corporate identification number (CIN) of Sri Krishna Pharmaceuticals Limited is U24230TG1974PLC001790 and the company number is 001790 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Sri Krishna Pharmaceuticals Limited?

    The Official website of Sri Krishna Pharmaceuticals Limited is https://www.srikrishnapharma.com

  • What has been the recent revenue trend for Sri Krishna Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Sri Krishna Pharmaceuticals Limited has fallen by -3.35%.

  • How many employees does Sri Krishna Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 1459 employees are currently employed by Sri Krishna Pharmaceuticals Limited.

  • What change has been observed in the net worth of Sri Krishna Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Sri Krishna Pharmaceuticals Limited has experienced an upsurge of 1.61%.

  • What are the total open charges for Sri Krishna Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Sri Krishna Pharmaceuticals Limited amount to ₹ 287.16 Cr.

  • When was the last Balance Sheet of Sri Krishna Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Sri Krishna Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed